• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物受体(RAGE)在大鼠和人肺中表现出高度不同的细胞和亚细胞定位。

Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung.

作者信息

Fehrenbach H, Kasper M, Tschernig T, Shearman M S, Schuh D, Müller M

机构信息

Institute of Pathology, University Clinics Carl Gustav Carus, Technical University of Dresden, Germany.

出版信息

Cell Mol Biol (Noisy-le-grand). 1998 Nov;44(7):1147-57.

PMID:9846897
Abstract

The transmembrane receptor (RAGE) of advanced glycation endproducts (AGEs), is abundantly present in the lung. Although the interaction of AGEs and RAGE plays an important role in vasculopathies, particularly in diabetes, the lung is not a classical target organ of diabetes. Thus, the role of RAGE in the lung is still obscure. This study sought to precisely localise RAGE in the lungs of rat and human by immunohistochemistry, double immunofluorescence and immunoelectron microscopy using a polyclonal antiserum developed against human recombinant RAGE. Anti-RAGE immunoreactivity was prominent in alveolar epithelial type I pneumocytes, while it was absent from type II pneumocytes and capillary endothelium. Cell type specificity was demonstrated by colocalisation with well established cell markers. Quantitative immunoelectron microscopy of cryo-substituted, Lowicryl-embedded rat and human specimens demonstrated a unique labelling pattern of RAGE in that it selectively localised to the basal cell membrane of type I pneumocytes. Labelling pattern was independent of the mode of fixation. Equivalent labelling densities were calculated from a fibrotic rat lung 3 months after irradiation. This highly selective localisation of RAGE to the basal face of type I pneumocytes and its absence from capillary endothelium might explain the resistance of the lung to typical diabetic complications.

摘要

晚期糖基化终末产物(AGEs)的跨膜受体(RAGE)在肺中大量存在。尽管AGEs与RAGE的相互作用在血管病变尤其是糖尿病中起重要作用,但肺并非糖尿病的典型靶器官。因此,RAGE在肺中的作用仍不清楚。本研究旨在通过免疫组织化学、双重免疫荧光和免疫电子显微镜技术,使用针对人重组RAGE制备的多克隆抗血清,精确地在大鼠和人的肺中定位RAGE。抗RAGE免疫反应在I型肺泡上皮细胞中很突出,而在II型肺泡上皮细胞和毛细血管内皮细胞中则不存在。通过与成熟的细胞标志物共定位证明了细胞类型特异性。对经冷冻置换、Lowicryl包埋的大鼠和人标本进行的定量免疫电子显微镜研究显示,RAGE具有独特的标记模式,即它选择性地定位于I型肺泡上皮细胞的基底细胞膜。标记模式与固定方式无关。从照射后3个月的纤维化大鼠肺中计算出等效的标记密度。RAGE在I型肺泡上皮细胞基底面的这种高度选择性定位以及在毛细血管内皮细胞中的缺失,可能解释了肺对典型糖尿病并发症的抵抗力。

相似文献

1
Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung.晚期糖基化终末产物受体(RAGE)在大鼠和人肺中表现出高度不同的细胞和亚细胞定位。
Cell Mol Biol (Noisy-le-grand). 1998 Nov;44(7):1147-57.
2
Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.晚期糖基化终产物及其受体在易受糖尿病微血管损伤的大鼠器官中共定位。
Diabetologia. 1997 Jun;40(6):619-28. doi: 10.1007/s001250050725.
3
Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene.肺中的II型肺泡上皮细胞表达晚期糖基化终产物受体(RAGE)基因。
Biochem Biophys Res Commun. 1997 Sep 18;238(2):512-6. doi: 10.1006/bbrc.1997.7263.
4
The human and rat recombinant receptors for advanced glycation end products have a high degree of homology but different pharmacokinetic properties in rats.人源和大鼠重组晚期糖基化终产物受体具有高度同源性,但在大鼠体内具有不同的药代动力学特性。
J Pharmacol Exp Ther. 1999 Sep;290(3):1458-66.
5
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.在人血管内皮细胞和平滑肌细胞中表达的晚期糖基化终产物受体的新型剪接变体及其在糖尿病诱导的血管损伤中的假定作用。
Biochem J. 2003 Mar 15;370(Pt 3):1097-109. doi: 10.1042/BJ20021371.
6
Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.晚期糖基化终产物内源性分泌受体的小鼠直系同源物的鉴定:结构、功能与表达
Biochem J. 2006 May 15;396(1):109-15. doi: 10.1042/BJ20051573.
7
Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR.晚期糖基化终末产物受体在2型糖尿病合并慢性牙周病患者牙龈组织中的表达:一项利用免疫组织化学和逆转录-聚合酶链反应的研究
J Clin Periodontol. 2005 Jan;32(1):40-4. doi: 10.1111/j.1600-051X.2004.00623.x.
8
Association of advanced glycation end products with A549 cells, a human pulmonary epithelial cell line, is mediated by a receptor distinct from the scavenger receptor family and RAGE.晚期糖基化终末产物与人类肺上皮细胞系A549细胞的结合是由一种不同于清道夫受体家族和RAGE的受体介导的。
J Biochem. 2006 May;139(5):821-9. doi: 10.1093/jb/mvj092.
9
Advanced glycation end products: sparking the development of diabetic vascular injury.晚期糖基化终末产物:引发糖尿病血管损伤的发展
Circulation. 2006 Aug 8;114(6):597-605. doi: 10.1161/CIRCULATIONAHA.106.621854.
10
Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.间皮细胞的肌成纤维细胞转分化由晚期糖基化终末产物受体(RAGE)介导,并促成尿毒症中的腹膜纤维化。
Nephrol Dial Transplant. 2006 Sep;21(9):2549-55. doi: 10.1093/ndt/gfl271. Epub 2006 Jun 6.

引用本文的文献

1
Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses.晚期糖基化终末产物受体(RAGE)及其配体在炎症反应中的作用。
Biomolecules. 2024 Dec 4;14(12):1550. doi: 10.3390/biom14121550.
2
Distribution and volume of mitochondria in alveolar epithelial type 1 cells in infant and adult human lungs.婴儿和成人肺中肺泡上皮 1 型细胞中线粒体的分布和数量。
Histochem Cell Biol. 2024 Nov 18;163(1):7. doi: 10.1007/s00418-024-02332-7.
3
Role of the receptor for advanced glycation end products in the severity of SARS-CoV-2 infection in diabetic patients.
晚期糖基化终末产物受体在糖尿病患者感染严重急性呼吸综合征冠状病毒2中的作用。
Diabetol Int. 2024 Jul 26;15(4):732-744. doi: 10.1007/s13340-024-00746-1. eCollection 2024 Oct.
4
Breathing new life into the study of COPD with genes identified from genome-wide association studies.从全基因组关联研究中鉴定出的基因为 COPD 研究注入新活力。
Eur Respir Rev. 2024 May 29;33(172). doi: 10.1183/16000617.0019-2024. Print 2024 Apr 30.
5
RAGE Is a Receptor for SARS-CoV-2 N Protein and Mediates N Protein-induced Acute Lung Injury.RAGE 是 SARS-CoV-2 N 蛋白的受体,介导 N 蛋白诱导的急性肺损伤。
Am J Respir Cell Mol Biol. 2023 Nov;69(5):508-520. doi: 10.1165/rcmb.2022-0351OC.
6
The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD.晚期糖基化终末产物-晚期糖基化终末产物受体轴与慢性阻塞性肺疾病的多病共存病理生理学
J Clin Med. 2023 May 9;12(10):3366. doi: 10.3390/jcm12103366.
7
RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review.RAGE 抑制剂在癌症靶向治疗中的应用:全面综述。
Int J Mol Sci. 2022 Dec 23;24(1):266. doi: 10.3390/ijms24010266.
8
Advanced development and mechanism of sepsis-related acute respiratory distress syndrome.脓毒症相关急性呼吸窘迫综合征的研究进展与发病机制
Front Med (Lausanne). 2022 Nov 14;9:1043859. doi: 10.3389/fmed.2022.1043859. eCollection 2022.
9
COVID-19 and diabetes: What do we know so far?新型冠状病毒肺炎与糖尿病:目前我们了解多少?
Exp Biol Med (Maywood). 2022 Aug;247(15):1330-1334. doi: 10.1177/15353702221108914. Epub 2022 Jul 27.
10
Impairing RAGE signaling promotes survival and limits disease pathogenesis following SARS-CoV-2 infection in mice.抑制 RAGE 信号通路可促进感染 SARS-CoV-2 的小鼠的存活并限制疾病发病机制。
JCI Insight. 2022 Jan 25;7(2):e155896. doi: 10.1172/jci.insight.155896.